Drug Atlas

NDC 78670-003 – Revonto

Dantrolene Sodium 20 mg/60mL · Injection, Powder, Lyophilized, For Solution · Intravenous

Human Prescription Drug 1 recall

Product NDC78670-003

Product details

Brand name: Revonto
Generic name: Dantrolene sodium
Labeler: USWM, LLC
Dosage form: Injection, Powder, Lyophilized, For Solution
Route: Intravenous
Marketing category: ANDA · ANDA078378
Marketed since: April 9, 2021
Listing expires: December 31, 2026
Pharmacologic class: Skeletal Muscle Relaxant

Active ingredients

Dantrolene Sodium 20 mg/60mL

Uses, dosage, side effects and warnings for Revonto →

Package NDC codes (1)

Package NDC	Description	Since
78670-003-67	6 VIAL, GLASS in 1 CARTON (78670-003-67) / 60 mL in 1 VIAL, GLASS	Apr 9, 2021

Recalls mentioning this NDC

D-1081-2022 Jun 15, 2022 · Class II
cGMP deviations: Temperature abuse

Other Revonto products

84549-003 Dantrolene Sodium 20 mg/60mL · Injection, Powder, Lyophilized, For Solution · ProPharma Distribution